See more : Zovio Inc (ZVOI) Income Statement Analysis – Financial Results
Complete financial analysis of Aterian, Inc. (ATER) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aterian, Inc., a leading company in the Furnishings, Fixtures & Appliances industry within the Consumer Cyclical sector.
- Gamelancer Media Corp. (VRTS.TO) Income Statement Analysis – Financial Results
- Network Media Group Inc. (NTE.V) Income Statement Analysis – Financial Results
- CHAR Technologies Ltd. (YES.V) Income Statement Analysis – Financial Results
- Clean Power Hydrogen Plc (CPH2.L) Income Statement Analysis – Financial Results
- PACCAR Inc (PCAR) Income Statement Analysis – Financial Results
Aterian, Inc. (ATER)
Industry: Furnishings, Fixtures & Appliances
Sector: Consumer Cyclical
Website: https://www.aterian.io
About Aterian, Inc.
Aterian, Inc., together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. The company provides Artificial Intelligence Marketplace e-Commerce Engine, a software technology platform, which uses machine learning, natural language processing, and data analytics to design, develop, market, and sell products. Its platform offers home and kitchen appliances; kitchenware; heating, cooling, and health and beauty products; and air quality appliances, such as dehumidifiers, humidifiers, and air conditioners under the hOmeLabs, Vremi, Squatty Potty, Xtava, RIF6, Aussie Health, Holonix, Truweo, Mueller, Pursteam, Pohl and Schmitt, Healing Solutions, Photo Paper Direct, and Spiralizer brands. The company also sells essential oils. It primarily serves individual online consumers through Amazon and other e-commerce platforms, as well as through its owned and operated websites and other marketplaces. The company was formerly known as Mohawk Group Holdings, Inc. and changed its name to Aterian, Inc. in April 2021. Aterian, Inc. was founded in 2014 and is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 142.57M | 221.17M | 247.77M | 185.70M | 114.45M | 73.28M | 36.46M |
| Cost of Revenue | 72.28M | 115.65M | 125.90M | 100.96M | 69.41M | 47.30M | 22.78M |
| Gross Profit | 70.29M | 105.52M | 121.86M | 84.75M | 45.04M | 25.98M | 13.68M |
| Gross Profit Ratio | 49.30% | 47.71% | 49.18% | 45.63% | 39.35% | 35.46% | 37.52% |
| Research & Development | 4.62M | 6.01M | 9.84M | 8.13M | 8.13M | 3.66M | 3.70M |
| General & Administrative | 20.22M | 38.24M | 43.80M | 30.63M | 23.78M | 11.29M | 5.65M |
| Selling & Marketing | 81.91M | 121.14M | 127.37M | 68.01M | 52.03M | 40.47M | 26.93M |
| SG&A | 102.13M | 159.38M | 171.17M | 98.64M | 75.81M | 51.76M | 32.57M |
| Other Expenses | 39.73M | -18.39M | -45.00K | 27.00K | -41.00K | 14.00K | -24.00K |
| Operating Expenses | 146.48M | 165.39M | 181.01M | 106.77M | 83.94M | 55.41M | 36.27M |
| Cost & Expenses | 218.76M | 281.04M | 306.91M | 207.72M | 153.35M | 102.71M | 59.05M |
| Interest Income | 704.00K | 93.00K | 595.00K | 59.00K | 146.00K | 1.00K | 1.00K |
| Interest Expense | 2.13M | 2.60M | 12.66M | 4.96M | 4.39M | 2.35M | 413.00K |
| Depreciation & Amortization | 3.89M | 7.52M | 7.33M | 552.00K | 183.00K | 253.00K | 258.00K |
| EBITDA | -69.42M | -186.45M | -214.92M | -57.49M | -54.05M | -29.16M | -22.36M |
| EBITDA Ratio | -48.69% | -31.98% | -20.93% | -11.55% | -33.86% | -39.79% | -61.32% |
| Operating Income | -76.19M | -59.87M | -59.14M | -22.02M | -38.90M | -29.43M | -22.59M |
| Operating Income Ratio | -53.44% | -27.07% | -23.87% | -11.86% | -33.99% | -40.16% | -61.97% |
| Total Other Income/Expenses | 759.00K | -18.51M | -201.42M | -28.33M | -4.43M | -2.34M | -436.00K |
| Income Before Tax | -75.43M | -196.67M | -234.19M | -63.08M | -43.33M | -31.77M | -23.03M |
| Income Before Tax Ratio | -52.91% | -88.92% | -94.52% | -33.97% | -37.86% | -43.35% | -63.16% |
| Income Tax Expense | -867.00K | -376.00K | 532.00K | 48.00K | 29.00K | 55.00K | 38.00K |
| Net Income | -74.56M | -196.29M | -234.72M | -63.13M | -43.36M | -31.82M | -23.07M |
| Net Income Ratio | -52.30% | -88.75% | -94.74% | -33.99% | -37.88% | -43.43% | -63.27% |
| EPS | -11.45 | -35.41 | -11.26 | -3.32 | -2.86 | -1.81 | -1.32 |
| EPS Diluted | -11.45 | -35.41 | -11.26 | -3.32 | -2.86 | -1.81 | -1.32 |
| Weighted Avg Shares Out | 6.51M | 5.54M | 20.84M | 18.99M | 15.13M | 17.54M | 17.54M |
| Weighted Avg Shares Out (Dil) | 6.51M | 5.54M | 20.84M | 18.99M | 15.13M | 17.54M | 17.54M |
Aterian, Inc. (ATER) Q3 2024 Earnings Call Transcript
Aterian Reports Third Quarter 2024 Results
Aterian's Prospects Are Improving Under New Leadership - Buy
Aterian Sets Date for Third Quarter 2024 Earnings Announcement & Investor Conference Call
Aterian, Inc. (ATER) Q2 2024 Earnings Call Transcript
Aterian Sets Date for Second Quarter 2024 Earnings Announcement & Investor Conference Call
Aterian: Cheap, But Speculative Turnaround Play - Upgrade To Buy
Aterian Announces Leadership Changes & Improved Second Quarter 2024 Net Revenue and Adjusted EBITDA Ranges
Aterian Investment Partners Acquires Contract Pharmaceuticals Limited
Aterian, Inc. (ATER) Q1 2024 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports